Yoshimichi Haruna
- Hepatology top 1%
- Hepatitis C virus research 16
- Liver physiology and pathology 3
- Liver Diseases and Immunity 3
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 9
- Hepatitis B Virus Studies 9
- Gastroenterology top 10%
-
- Hormonal Regulation and Hypertension 3
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Systemic Lupus Erythematosus Research 3
- Co-authors
- Michael A. NalesnikKo SaitoMichael A. GerberStephen W. SpauldingAkinori KasaharaHideyuki FusamotoNorio HayashiTakenobu Kamada
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Gastroenterology (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Yoshimichi Haruna
30 papers receiving 903 citations
Peers
Comparison fields: 5 of 78
- Hepatology 648
- Epidemiology 504
- Gastroenterology 48
- Surgery 270
- Endocrinology, Diabetes and Metabolism 66
Countries citing papers authored by Yoshimichi Haruna
This map shows the geographic impact of Yoshimichi Haruna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimichi Haruna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimichi Haruna more than expected).
Fields of papers citing papers by Yoshimichi Haruna
This network shows the impact of papers produced by Yoshimichi Haruna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimichi Haruna. The network helps show where Yoshimichi Haruna may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshimichi Haruna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 18 | |
| 2 | 2017 | 13 | |
| 3 | 2013 | 3 | |
| 4 | 2011 | 4 | |
| 5 | 2009 | 5 | |
| 6 | 2007 | 35 | |
| 7 | 2006 | 16 | |
| 8 | 2005 | 1 | |
| 9 | 2005 | 116 | |
| 10 | 2004 | 53 | |
| 11 | Hepatocellular carcinoma appearing after eight-year and six-month-long sustained viral response by interferon therapy for chronic hepatitis | 2003 | 1 |
| 12 | 2001 | 23 | |
| 13 | Administration of interferon alpha suppositories to HCV-infected patients suppressed HCV replication associated with decreased CD4/CD8 ratio and elevated 2 ’-5 ’ oligoadenylate synthetase activity in peripheral blood. | 2000 | 2 |
| 14 | 2000 | 11 | |
| 15 | 1996 | 169 | |
| 16 | 1996 | 3 | |
| 17 | 1995 | 18 | |
| 18 | 1994 | 37 | |
| 19 | 1993 | 63 | |
| 20 | 1992 | 2 |
About Yoshimichi Haruna
Yoshimichi Haruna is a scholar working on Hepatology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 31 papers that have together received 928 indexed citations. Recurring topics across this work include Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (9 papers), Hepatitis B Virus Studies (9 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Liver physiology and pathology (3 papers), Liver Diseases and Immunity (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Hormonal Regulation and Hypertension (3 papers). The work is most often cited by research in Hepatology (648 citations), Epidemiology (504 citations) and Gastroenterology (48 citations). Yoshimichi Haruna has collaborated with scholars based in Japan and United States. Frequent co-authors include Michael A. Nalesnik, Ko Saito, Michael A. Gerber, Stephen W. Spaulding, Akinori Kasahara, Hideyuki Fusamoto, Norio Hayashi, Takenobu Kamada, Tsutomu Kanda and Swan N. Thung. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.